tradingkey.logo

tradingkey.logo
怜玢


KORU Medical Systems Inc

KRMD
りォッチリストに远加
4.110USD
0.0000.00%
終倀 07-31 16:00ET15分遅れの株䟡
188.78M時䟡総額
損倱額盎近12ヶ月PER

詳现情報 KORU Medical Systems Inc 䌁業名

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Incの䌁業情報


䌁業コヌドKRMD
䌚瀟名KORU Medical Systems Inc
䞊堎日Oct 27, 1993
最高経営責任者「CEO」Tharby (Linda M)
埓業員数80
蚌刞皮類Ordinary Share
決算期末Oct 27
本瀟所圚地100 Corporate Drive
郜垂MAHWAH
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号07430
電話番号18454692042
りェブサむトhttps://www.korumedical.com/
䌁業コヌドKRMD
䞊堎日Oct 27, 1993
最高経営責任者「CEO」Tharby (Linda M)

KORU Medical Systems Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
51.31K
+6.96%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.20M
+0.65%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
312.50K
+4.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
308.99K
+2.87%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
101.14K
+3.53%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
98.51K
+3.62%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
98.16K
+3.64%

よくある質問

KORU Medical Systems Incの䞊䜍5名の株䞻は誰ですか


KORU Medical Systems Incの䞊䜍5名の株䞻は以䞋のずおりです。Ms. Linda M. Tharby

KORU Medical Systems IncKRMDの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、KORU Medical Systems Incの株匏を保有しおいる機関は188瀟あり、保有株匏の総垂堎䟡倀は玄28.85Mで、党䜓の62.71%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-129292.00増加しおいたす。

KORU Medical Systems Incの最倧の収益源は䜕ですか


2026Q1においお、Domestic Core郚門がKORU Medical Systems Incにずっお最倧の収益を生み出しおおり、その金額は27.99Mで、党収益の68.06%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。